Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Compugen Ltd. Report Publication Announcement 2007

Jan 30, 2007

6734_rns_2007-01-30_3e0f0451-1795-4c5a-af9a-7a0984502c5f.htm

Report Publication Announcement

Open in viewer

Opens in your device viewer

_________

C002�������� ��"�2PublicCOMPUGEN LTD.2521Corporation no: 511779639Stock Exchange/Market: ��������606380Pinchas Rosen 72 , Tel Aviv 69512 , ,Tel: 03-7658585 , 03-7658525 Fax: 03-7658555E.mail address: [email protected] of transmission: 30/01/2007              Time of broadcast: 14:06 14:04:15

Reference: 2007-02-022846

Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Compugen to Present Experimental Data of its MCP-1 Antagonist Candidate at GTCBio�s Cytokines and Inflammation Conference
6-kJanuary302007_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 01/01/2007
- - -
Name of the Signatory: : Benjamini Nurit , , Position of Signatory in the reporting corporation: Chief Financial Officer
Pinchas Rosen Telephone: 03-7658525 , Facsimile: 03-7658516 , E-mail: [email protected]